Updated: Nigeria records 35 new cases of COVID-19 as toll rises 174

By our reporter| The Nigeria Centre for Disease Control (NCDC) on Wednesday confirmed 35 new cases of coronavirus in the country.

In a tweet via its official twitter handle, the health agency gave a breakdown of the new cases as, nine in Lagos, nine, FCT, seven, Akwa Ibom, five, Kaduna and Bauchi, one each.

The tweet read, “As at 08:00 pm 1st April there are 174 confirmed cases of #COVID19 reported in Nigeria. Nine have been discharged with two deaths.”

Twenty-three new cases of #COVID19 have been reported in Nigeria; 9 in Lagos, 7 in the FCT, 5 in Akwa Ibom, 1 in Kaduna and 1 in Bauchi State

As at 08:00 pm 1st April there are 174 confirmed cases of #COVID19 reported in Nigeria. Nine have been discharged with two deaths”.

— NCDC (@NCDCgov) April 1, 2020.

The NCDC had earlier in the day announced 12 new cases from three states.

Since the index case of COVID-19 was recorded in Nigeria on February 28, a total of 174 persons have so far been infected with the disease across 11 states and the FCT.

Nine of them have been discharged while two died while receiving treatment.

Earlier on Wednesday, Osagie Ehanire, minister of health, said over 2,000 people have been tested for coronavirus and many expected the toll to rise with the increase in testing.

“As of now, well over 2,000 persons have been tested with the hope of further expanding and improving diagnostic capacity across the board to shorten turnaround time and increase the volume,” he said.

“Since this week, two more laboratories were added to the Nigerian Centre for Disease Control network of the molecular laboratories for COVID-19 at University College Ibadan and Federal Teaching Hospital Abakaliki, Ebonyi State, increasing our test sites to seven, to start scaling up testing capacity with the hope of further increase when human resources are mobilised for round-the-clock shift duty.

“As part of preparedness in the Abuja metropolis, we have over 1,000-bed spaces ready for isolation and treatment of mild to moderate cases, which we can expand if the need arises.”

Leave a Reply